Asahi Life Asset Management Co., Ltd. Medtronic PLC Transaction History

Asahi Life Asset Management Co., Ltd.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$82.84 - $88.09 $522,720 - $555,847	6,310 New	6,310 $549,000
Q2 2023 Jul 21, 2023	SELL	$79.47 - $91.38 $292,449 - $336,278	-3,680 Reduced 56.79%	2,800 $246,000
Q1 2023 May 01, 2023	BUY	$76.72 - $87.58 $497,145 - $567,518	6,480 New	6,480 $522,000
Q1 2022 May 11, 2022	SELL	$100.58 - $112.38 $359,070 - $401,196	-3,570 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$99.53 - $127.75 $254,796 - $327,040	2,560 Added 253.47%	3,570 $369,000
Q3 2021 Oct 29, 2021	SELL	$122.75 - $135.17 $367,022 - $404,158	-2,990 Reduced 74.75%	1,010 $127,000
Q2 2021 Aug 10, 2021	BUY	$118.19 - $131.5 $238,743 - $265,630	2,020 Added 102.02%	4,000 $497,000
Q1 2021 May 07, 2021	SELL	$111.18 - $119.74 $142,310 - $153,267	-1,280 Reduced 39.26%	1,980 $234,000
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $12,068 - $14,056	120 Added 3.82%	3,260 $382,000
Q3 2020 Nov 02, 2020	SELL	$90.13 - $108.78 $28,841 - $34,809	-320 Reduced 9.25%	3,140 $326,000
Q2 2020 Aug 05, 2020	SELL	$84.11 - $103.33 $469,333 - $576,581	-5,580 Reduced 61.73%	3,460 $317,000
Q1 2020 May 15, 2020	BUY	$72.92 - $121.3 $503,877 - $838,183	6,910 Added 324.41%	9,040 $815,000
Q4 2019 Feb 13, 2020	SELL	$104.49 - $114.54 $177,633 - $194,718	-1,700 Reduced 44.39%	2,130 $242,000
Q3 2019 Nov 13, 2019	SELL	$98.02 - $111.18 $387,179 - $439,161	-3,950 Reduced 50.77%	3,830 $416,000
Q2 2019 Aug 09, 2019	BUY	$84.15 - $99.38 $479,655 - $566,466	5,700 Added 274.04%	7,780 $758,000
Q4 2018 Feb 14, 2019	BUY	$85.8 - $99.49 $178,464 - $206,939	2,080 New	2,080 $189,000

2,350

1.06B

6.95M

8.08M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $123B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.